⚔️ War & Conflict
Live
Why Billionaire Stanley Druckenmiller and Wall Street Analysts Love This Biotech Stock
Written by James Halley for The Motley Fool -> Druckenmiller bought 316,000 shares of Revolution Medicines in the first quarter. The company doesn't generate revenue yet and lost $453 million in the f
Nasdaq News — 2 August 2026
Text:
7
0
0
Written by James Halley for The Motley Fool -> Druckenmiller bought 316,000 shares of Revolution Medicines in the first quarter. The company doesn't g
Read Full Story at Nasdaq News → Sources
⚔️ War & Conflict
Iranian missiles show deadly precision amid US-Iran war escalation
⚔️ War & Conflict
Mysterious white foam draws crowds on Nigerian highway
⚔️ War & Conflict
Telemundo’s World Cup 2026 Coverage Makes History Across All Platforms
⚔️ War & Conflict
‘There’s no salary’: DRC health workers tell of hardship as Ebola spreads
⚔️ War & Conflict
Ukraine’s Zelenskyy meets with far-right US activist Laura Loomer
⚔️ War & Conflict
How Russia is luring foreign nationals to fight in Ukraine
